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Dahui You, Rhett W. Stout, Christian Clement, 
Merlin Johnson, and Hilary Thompson
We	 tested	 laboratory	 rabbits	 from	 2	 US	 vendors	 for	 
antibodies	 against	 hepatitis	 E	 virus	 (HEV);	 Seropreva-
lences were 40% and 50%. Retrospective analysis of an 
ocular	herpes	simplex	1	experiment	demonstrated	that	HEV	
seropositivity	 had	no	effect	 on	experiment	 outcome.	HEV	
probably is widespread in research rabbits, but effects on 
research remain unknown.
Hepatitis E virus (HEV) is a single-stranded RNA vi-rus in the family Hepeviridae (1). HEV is transmitted 
through the fecal–oral and bloodborne routes and typically 
causes transient hepatitis; however, such infections can be 
fatal, especially in pregnant women (20% mortality rate) 
and in immunocompromised persons (2,3).
HEV has 4 genotypes, and genotypes 3 and 4 are found 
in humans and other animals (1). The genomic sequence 
of US rabbit HEV (GenBank accession no. JX565469) has 
been analyzed and the sequence places rabbit HEV as a dis-
tant member of the zoonotic HEV genotype 3 (4). A study in 
France found HEV in farmed and wild rabbits and charac-
terized a closely related human strain of HEV (5). Although 
HEV has been detected in rabbits from Asian and European 
counties, researchers previously thought that HEV was not 
a major presence in rabbits in the United States (5–7). A re-
cent study identified a 36% prevalence of HEV antibodies 
in animals on 2 rabbit farms in Virginia (1).
Because HEV may be a confounding factor in research 
and is a potential zoonotic pathogen (5), we tested rabbits 
from 2 US suppliers for HEV seroprevalence. Supplier A 
was a local conventional rabbit farm, and supplier B was 
a commercial vendor of specific pathogen free (SPF) re-
search rabbits. Our hypothesis was 3-fold: 1)HEV is a pos-
sibly undiagnosed pathogen in laboratory rabbits, 2) HEV 
seroprevalence is unlikely in rabbits from supplier B (a SPF 
supplier), and 3) HEV seroprevalence might confound re-
search. To investigate the latter hypothesis, we retrospec-
tively analyzed records from a subset of animals used in a 
herpes simplex 1 virus (HSV-1) research project.
The Study
Animals
Two shipments of New Zealand White rabbits (70 rab-
bits shipment 1 [rabbit nos. AN1–AN20 and AH1–AH30] 
in June 2012 to Louisiana State University Health Sciences 
Center [LSUHSC]; shipment 2 [rabbit nos. AH31–AH51] 
in October 2012) were obtained from supplier A at LSUH-
SC. Supplier A also provides rabbits to the meat produc-
tion industry. A third shipment comprising 10 Dutch Belted 
SPF rabbits (nos. DB1–DB10) were obtained from supplier 
B in August 2012 at LSUHSC. Supplier B rabbits were 
SPF for Pasturella multocida, Pasturella pneumotropica, 
Bordetella brochiseptica, Treponema cuniculi, Clostrid-
ium piliformis, cilia-associated respiratory bacillus, Sal-
monella spp., Encephalitozoon cuniculi, Eimeria stiedae, 
Eimeria magna, Eimeria intestinalis, Eimeria irresidua, 
Eimeria flavescens, Eimeria piriformis, Toxoplasma gon-
dii, Passalurus ambiguous, other helminths, parainfluenza 
virus 1, parainfluenza virus 2, reovirus, Psoroptes cuniculi, 
Cheyletiella parasitovorax, Leporacarus gibbus, and Der-
matomycosis spp.
The rabbits’ care and use were approved by the 
LSUHSC Institutional Animal Care and Use Commit-
tee and were consistent with the Guide for the Care and 
Use of Laboratory Animals (8) and the Animal Welfare 
Act (http://www.aphis.usda.gov/animal_welfare/). The 
LSUHSC is fully accredited by American Association 
for the Assessment of Laboratory Animal Care, Int. The 
animals were singly housed in stainless steel rabbit cages 
(Suburban Surgical, Wheeling, IL, USA). On the day the 
rabbits arrived, blood was collected from each rabbit and 
stored for HEV testing. Rabbits from vendor A were treat-
ed for P. cuniculi and L. gibbus with selamectin (Pfizer 
New York, NY, USA). After arrival, the rabbits were ac-
climated to the facility for 7 days. After this period, they 
were used for research protocols approved by the Institu-
tional Animal Care and Use Committee.
Sample Collection
Approximately 0.5–1 mL of blood was collected 
through the rabbits’ middle auricular artery with a 25-gauge 
butterfly catheter. The blood was placed into serum sepa-
rator tubes for centrifugation. Serum was then placed into 
microcentrifuge tubes and stored at –20°C until analysis. 
Laboratory personnel changed gloves between blood col-
lection from each rabbit and between contact with each 
sample when transferring serum.
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HEV Infection and Outcome of Rabbit Model  
of Ocular HSV-1
The records of 30 animals from supplier A (AH1–
AH30) were obtained retrospectively from an investigator 
who used the rabbits in an HSV-1 ocular keratitis study. 
Survival data and HEV antibody status were examined sta-
tistically to determine whether HEV status had any effect 
on the survival of the rabbits in the study. Briefly, 4 differ-
ent strains of HSV-1 with different virulence levels were 
tested, including MCK D-gK, ICP0-delete, 17 syn + mu-
tant, and McKrae. Rabbits were infected with these viruses, 
and keratitis score and survival rate were recorded.
ELISA
ELISA was performed by using the protocol from 
Cossaboom et al. with a few modifications (1). Plates 
(Fischer Scientific, Waltham, MA, USA) were coated with 
6 µg HEV antigen (Clone# rHEV-ORF2; Feldan Bio Inc., 
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Figure	 1.	Hepatitis	 E	 virus	 antibody	 detection	 for	 rabbits	 from	 supplier	A,	 shipment	 1	 (June	 2012,	 Louisiana	State	University	Health	
Sciences Center). Rabbits were purchased from supplier A. Serum was isolated and antibodies in the serum were measured by using 
ELISA.	Rabbit	identification	numbers	are	listed	on	the	x-axis	and	the	mean	+	SD	optical	density	of	each	sample	is	listed	on	the	y-axis.	 





line. White bars indicate controls. +, positive control; –, negative control.
Hepatitis	E	Antibodies	in	Laboratory	Rabbits
Quebec, QC, Canada), incubated with 100 µL of rabbit se-
rum diluted 10-fold in blocking buffer, and detected with 
horseradish peroxidase–conjugated secondary antibody 
(goat anti–rabbit IgG diluted 1:1000, Southern Biotech, 
Birmingham, AL, USA). The plates were read at 450 nm 
and 540 nm for correction on a SpectraMax M2 plate read-
er (Molecular Devices, Sunnyvale, CA, USA).
Statistical Analysis
ELISAs for HEV were performed in duplicate on 
each serum sample, and the results were averaged. A 
1-way analysis of variance was performed to find the op-
tical densities that were not statistically different from 
those of the negative controls. The values of the nega-
tive controls and the negative samples were then used to 
determine the cutoff points for the ELISA (mean of the 
negative samples + 3 SDs).
To evaluate the possible effect of HEV serology sta-
tus on the survival of rabbits used in the HSV-1 study, we 
used the Fisher exact test when HSV-1 survival status was 
cross-tabulated with the HEV serology status. Odds ratios 
are also reported (SAS, version 9.3, SAS Institute, Cary, 
NC, USA); α was set at 0.05.
Prevalence of HEV in US Laboratory Rabbits
We found that the seroprevalence of HEV in the 70 
rabbits from supplier A was 40%. The 10 rabbits from sup-
plier B exhibited a 50% seroprevalence for HEV (Figures 
1 and 2).
HEV Infection and Disease Outcome of  
HSV-1–infected Animals
HSV-1 outcome results revealed no significant as-
sociation between positive serologic HEV status and fre-
quency of HSV-1 signs. Prevalence of positive HEV status 
was 32% (6/19) , compared with 36% (4/11) (p = 0.298, 
odds ratio 1.238, 95% CI 0.2592–5.9132) for frequency of 
HSV-1 signs.
Conclusions
We sought to determine the seroprevalence of HEV 
in research rabbits within LSUHSC. We were surprised to 
identify HEV-seropositive rabbits from the SPF research 
rabbit supplier (supplier B) because of the strict health 
quality standards employed at this supplier. The difference 
in HEV seroprevalence between the 2 vendors may be a 
function of sample numbers. Testing a larger number of 
samples from supplier B would answer this question. HEV 
may be widespread in research facilities throughout the 
United States.
Statistically, we could not demonstrate any effect of 
HEV serology status on the survival outcome or kera-
titis scores of HSV-1–infected rabbits. However, the 
interpretation of these results is limited because only 
tested for HEV only by serologic testing and not reverse 
transcription PCR. Controlled studies in which rabbits 
are experimentally infected with HEV and then later in-
fected with another pathogen are needed to determine 
the true effects of HEV co-infection on the outcome of 
systemic infection experiments in rabbits. 
Rabbits are commonly used in research and they 
often housed in a conventional setting. Because HEV is 
classified as a Biosafety Level-2 pathogen, wearing per-
sonnel protective protection equipment, such as masks, 
laboratory coats, and gloves, when working with rabbits 
is warranted (9,10). Laboratory animal care personnel, re-
searchers, and support staff represent a new population at 
risk for HEV infection, and research facilities should be 
diligent in measures to prevention of this possibly zoo-
notic pathogen.
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